Drug-nucleic acid interactions: conformational flexibility at the intercalation site. 1978

H M Berman, and S Neidle, and R K Stodola

The conformational features of the intercalation site in polynucleotides were examined. We found that, for all the crystal structures of drug-dinucleoside complexes studied thus far, two torsion angles differ from those found in A RNA (phi and chi) and that alternate sugar puckering is not a prerequisite for intercalation. This intercalation geometry, which is the basis of helix axis displacement in a polymer, would necessitate conformational changes in the adjacent nucleotides. The base-turn angle is less sensitive to the conformation of the backbone than it is to small alterations in the base-pairing geometry. We postulate that this angle is dependent on the nature of the intercalating drug.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D009696 Nucleic Acids High molecular weight polymers containing a mixture of purine and pyrimidine nucleotides chained together by ribose or deoxyribose linkages. Nucleic Acid,Acid, Nucleic,Acids, Nucleic
D004364 Pharmaceutical Preparations Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form. Drug,Drugs,Pharmaceutical,Pharmaceutical Preparation,Pharmaceutical Product,Pharmaceutic Preparations,Pharmaceutical Products,Pharmaceuticals,Preparations, Pharmaceutical,Preparation, Pharmaceutical,Preparations, Pharmaceutic,Product, Pharmaceutical,Products, Pharmaceutical

Related Publications

H M Berman, and S Neidle, and R K Stodola
January 1981, Annals of the New York Academy of Sciences,
H M Berman, and S Neidle, and R K Stodola
December 2011, The journal of physical chemistry. B,
H M Berman, and S Neidle, and R K Stodola
August 1979, Journal of theoretical biology,
H M Berman, and S Neidle, and R K Stodola
September 1968, Proceedings of the National Academy of Sciences of the United States of America,
H M Berman, and S Neidle, and R K Stodola
February 2019, Organic & biomolecular chemistry,
H M Berman, and S Neidle, and R K Stodola
February 1982, CRC critical reviews in biochemistry,
H M Berman, and S Neidle, and R K Stodola
May 2006, The journal of physical chemistry. B,
H M Berman, and S Neidle, and R K Stodola
September 1999, Proceedings of the National Academy of Sciences of the United States of America,
H M Berman, and S Neidle, and R K Stodola
December 1984, Biochemical Society transactions,
Copied contents to your clipboard!